Tenet Healthcare
About: Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Employees: 106,500
0
Funds holding %
of 7,139 funds
0
Analysts bullish %
of 8 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
58% more call options, than puts
Call options by funds: $370M | Put options by funds: $234M
6.14% more ownership
Funds ownership: 89.73% [Q3] → 95.87% (+6.14%) [Q4]
7% less funds holding
Funds holding: 598 [Q3] → 555 (-43) [Q4]
12% less repeat investments, than reductions
Existing positions increased: 193 | Existing positions reduced: 220
15% less first-time investments, than exits
New positions opened: 81 | Existing positions closed: 95
21% less capital invested
Capital invested by funds: $14.5B [Q3] → $11.4B (-$3.1B) [Q4]
42% less funds holding in top 10
Funds holding in top 10: 19 [Q3] → 11 (-8) [Q4]
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$140
8%
upside
Avg. target
$170
31%
upside
High target
$195
50%
upside
8 analyst ratings
6 positive
75%
2 neutral
25%
0 negative
0%
Cantor Fitzgerald Sarah James 31% 1-year accuracy 38 / 124 met price target | 37%upside $177 | Overweight Reiterated | 13 Feb 2025 |
Barclays Andrew Mok 38% 1-year accuracy 26 / 68 met price target | 24%upside $161 | Overweight Maintained | 13 Feb 2025 |
Keybanc Tim Rezvan 42% 1-year accuracy 16 / 38 met price target | 43%upside $185 | Overweight Maintained | 7 Jan 2025 |
Truist Securities David Macdonald 59% 1-year accuracy 57 / 96 met price target | 35%upside $175 | Buy Maintained | 6 Jan 2025 |
JP Morgan Benjamin Rossi 100% 1-year accuracy 1 / 1 met price target | 35%upside $175 | Overweight Assumed | 17 Dec 2024 |
Financial journalist opinion
Based on 15 articles about THC published over the past 30 days
Positive
Zacks Investment Research
1 week ago
Tenet Q4 Earnings Beat Estimates on Favorable Payer Mix
THC expects net operating revenues between $20.6 billion and $21 billion in 2025.
Neutral
Seeking Alpha
1 week ago
Tenet Healthcare Corporation (THC) Q4 2024 Earnings Call Transcript
Tenet Healthcare Corporation (NYSE:THC ) Q4 2024 Earnings Conference Call February 12, 2025 10:00 AM ET Company Participants Will McDowell - Vice President of Investor Relations Saumya Sutaria - Chairman and Chief Executive Officer Sun Park - Executive Vice President and Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Jamie Perse - Goldman Sachs Brian Tanquilut - Jefferies Andrew Mok - Barclays Justin Lake - Wolfe Research Benjamin Rossi - JPMorgan Chase Joanna Gajuk - Bank of America A.J Rice - UBS Stephen Baxter - Wells Fargo Michael Ha - Baird Ann Hynes - Mizuho Whit Mayo - Leerink Partners John Ransom - Raymond James Josh Raskin - Nephron Research Matthew Gillmor - KeyBanc Mike Murray - RBC Capital Markets Operator Good morning. Welcome to Tenet Healthcare's Fourth Quarter 2024 Earnings Conference Call.
Positive
Zacks Investment Research
1 week ago
Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics
The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Positive
Zacks Investment Research
1 week ago
Tenet Healthcare (THC) Surpasses Q4 Earnings Estimates
Tenet Healthcare (THC) came out with quarterly earnings of $3.44 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.68 per share a year ago.
Neutral
Business Wire
1 week ago
Tenet Reports Strong Fourth Quarter and FY 2024 Results; Provides 2025 Financial Outlook
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2024. "2024 was an outstanding year for Tenet characterized by robust revenue growth, efficient operations, high levels of patient satisfaction and clinical quality, and a portfolio transformation that drove substantial balance sheet deleveraging," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "Our focused strategy, disciplined operat.
Neutral
Zacks Investment Research
1 week ago
Can Tenet Healthcare Navigate Through Lower Revenues in Q4?
THC's fourth-quarter results are likely to reflect growing patient admissions, utilization and patient days.
Negative
Zacks Investment Research
2 weeks ago
Wall Street Analysts See Tenet (THC) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Neutral
Zacks Investment Research
2 weeks ago
Countdown to Tenet (THC) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Neutral
Zacks Investment Research
2 weeks ago
Tenet Healthcare (THC) Stock Drops Despite Market Gains: Important Facts to Note
Tenet Healthcare (THC) closed the most recent trading day at $143.71, moving -0.64% from the previous trading session.
Positive
Zacks Investment Research
2 weeks ago
Thriving in Healthcare: 5 Hospital Stocks to Keep on Your Radar
The Zacks Medical-Hospital industry is likely to benefit from improving financial, operating and staffing stability. Companies like HCA, THC, UHS, ACHC and CYH are well-positioned to gain from these trends.
Charts implemented using Lightweight Charts™